WPD Pharmaceuticals Inc. (WPDPF)
USD 0.0
(0.0%)
USD 0.0
(0.0%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | -60.44 Thousand USD | -102.12% |
| 2022 | 2.84 Million USD | 164.01% |
| 2021 | -4.44 Million USD | 24.71% |
| 2020 | -5.9 Million USD | 33.98% |
| 2019 | -8.94 Million USD | -1407.07% |
| 2018 | -593.49 Thousand USD | -71.98% |
| 2017 | -345.09 Thousand USD | -120.41% |
| 2016 | -156.57 Thousand USD | -898.23% |
| 2015 | -15.68 Thousand USD | 66.7% |
| 2014 | -47.1 Thousand USD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q2 | -13.88 Thousand USD | 87.94% |
| 2024 Q1 | -116.35 Thousand USD | -228.78% |
| 2023 FY | -60.42 Thousand USD | -102.12% |
| 2023 Q3 | -63.19 Thousand USD | -6.51% |
| 2023 Q1 | -28.07 Thousand USD | -100.46% |
| 2023 Q2 | -59.33 Thousand USD | -111.35% |
| 2023 Q4 | 92.34 Thousand USD | 246.12% |
| 2022 Q4 | 6.16 Million CAD | 765.98% |
| 2022 FY | 2.84 Million USD | 164.01% |
| 2022 Q1 | -456.84 Thousand USD | 77.2% |
| 2022 Q3 | -926.22 Thousand CAD | -46.69% |
| 2022 Q2 | -631.39 Thousand USD | -38.21% |
| 2021 Q4 | -2 Million USD | -259.27% |
| 2021 Q1 | -919.54 Thousand USD | 33.81% |
| 2021 FY | -4.44 Million USD | 24.71% |
| 2021 Q3 | -557.75 Thousand USD | 43.63% |
| 2021 Q2 | -989.46 Thousand USD | -7.6% |
| 2020 Q3 | -944.66 Thousand USD | 42.92% |
| 2020 FY | -5.9 Million USD | 33.98% |
| 2020 Q4 | -1.38 Million USD | -47.07% |
| 2020 Q2 | -1.65 Million USD | 0.0% |
| 2019 FY | -8.94 Million USD | -1407.07% |
| 2018 FY | -593.49 Thousand USD | -71.98% |
| 2017 FY | -345.09 Thousand USD | -120.41% |
| 2016 FY | -156.57 Thousand USD | -898.23% |
| 2015 FY | -15.68 Thousand USD | 66.7% |
| 2014 FY | -47.1 Thousand USD | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Burzynski Research Institute, Inc. | -1.33 Million USD | 95.474% |
| Arch Therapeutics, Inc. | -6.98 Million USD | 99.134% |
| Evofem Biosciences, Inc. | 52.97 Million USD | 100.114% |
| Nascent Biotech, Inc. | -2.08 Million USD | 97.105% |
| Rebus Holdings, Inc. | -1.02 Million USD | 94.074% |
| Santhera Pharmaceuticals Holding AG | 65.13 Million USD | 100.093% |
| Qrons Inc. | -789.34 Thousand USD | 92.343% |
| Adynxx, Inc. | - USD | Infinity% |
| Neon Bloom, Inc. | -632.4 Thousand USD | 90.443% |
| Northwest Biotherapeutics, Inc. | -62.59 Million USD | 99.903% |
| ProtoKinetix, Incorporated | -415.47 Thousand USD | 85.453% |
| Skye Bioscience, Inc. | -37.64 Million USD | 99.839% |
| Eiger BioPharmaceuticals, Inc. | -74.96 Million USD | 99.919% |
| Nanobac Pharmaceuticals, Incorporated | -6.57 Million USD | 99.081% |
| Institute of Biomedical Research Corp. | -273.4 Thousand USD | 77.893% |
| SQZ Biotechnologies Company | -79.46 Million USD | 99.924% |
| Intellipharmaceutics International Inc. | -2.89 Million USD | 97.91% |
| Propanc Biopharma, Inc. | -1.82 Million USD | 96.68% |
| Mesoblast Limited | -87.95 Million USD | 99.931% |
| Marizyme, Inc. | -65.34 Million USD | 99.908% |
| Genus plc | 7.9 Million USD | 100.765% |
| VioQuest Pharmaceuticals, Inc. | -10.89 Million USD | 99.445% |
| Pharming Group N.V. | -10.54 Million USD | 99.427% |
| Therapeutic Solutions International, Inc. | -2.16 Million USD | 97.214% |
| CNBX Pharmaceuticals Inc. | -3.71 Million USD | 98.371% |
| Nymox Pharmaceutical Corporation | -8.84 Million USD | 99.317% |
| ContraFect Corporation | -65.15 Million USD | 99.907% |
| PsyBio Therapeutics Corp. | -4.88 Million USD | 98.763% |
| Sienna Biopharmaceuticals, Inc. | - USD | Infinity% |
| RegeneRx Biopharmaceuticals, Inc. | -1.72 Million USD | 96.501% |
| IMV Inc. | -36.48 Million USD | 99.834% |
| AXIM Biotechnologies, Inc. | -8.05 Million USD | 99.25% |
| MultiCell Technologies, Inc. | -380.07 USD | -15802.494% |
| ONE Bio Corp. | 8.67 Million USD | 100.697% |
| Accustem Sciences Inc. | -3.74 Million USD | 98.387% |
| RVL Pharmaceuticals plc | -51.69 Million USD | 99.883% |
| Arno Therapeutics, Inc. | - USD | Infinity% |
| EV Biologics, Inc. | -1.26 Million USD | 95.23% |
| Q BioMed Inc. | -2.05 Million USD | 97.055% |
| Emmaus Life Sciences, Inc. | -3.73 Million USD | 98.381% |
| Mosaic ImmunoEngineering Inc. | -2.38 Million USD | 97.461% |
| Biomind Labs Inc. | -1.21 Million USD | 95.023% |
| American Oriental Bioengineering, Inc. | -59.72 Million USD | 99.899% |
| Provectus Biopharmaceuticals, Inc. | -3.1 Million USD | 98.051% |
| TetraLogic Pharmaceuticals Corporation | - USD | Infinity% |
| Oncotelic Therapeutics, Inc. | -7.9 Million USD | 99.235% |
| GlobeStar Therapeutics Corporation | -1.94 Million USD | 96.899% |
| THC Farmaceuticals, Inc. | -14.97 Thousand USD | -303.583% |
| Acro Biomedical Co., Ltd. | -15.87 Million USD | 99.619% |
| Curative Biotechnology, Inc. | -5.81 Million USD | 98.961% |
| GB Sciences, Inc. | -1.36 Million USD | 95.561% |
| Alpha Cognition Inc. | -13.77 Million USD | 99.561% |
| HST Global, Inc. | -146.21 Thousand USD | 58.662% |
| CSL Limited | 2.64 Billion USD | 100.002% |
| Wesana Health Holdings Inc. | -1.75 Million USD | 96.556% |
| Halberd Corporation | -79.67 Thousand USD | 24.142% |
| Enzolytics Inc. | -2.17 Million USD | 97.223% |
| Agentix Corp. | -1.37 Million USD | 95.602% |
| Resverlogix Corp. | -3.61 Million USD | 98.326% |
| Nuo Therapeutics, Inc. | -3.17 Million USD | 98.094% |
| MetaStat, Inc. | - USD | Infinity% |
| argenx SE | -295.05 Million USD | 99.98% |
| Enzon Pharmaceuticals, Inc. | 98 Thousand USD | 161.674% |
| Endonovo Therapeutics, Inc. | 6.92 Million USD | 100.873% |
| RespireRx Pharmaceuticals Inc. | -3.97 Million USD | 98.479% |
| GeneThera, Inc. | - USD | Infinity% |
| Inhibitor Therapeutics, Inc. | -3.02 Million USD | 98.003% |
| AVAX Technologies, Inc. | -6.41 Million USD | 99.058% |
| Zenith Capital Corp. | -10.59 Million USD | 99.43% |
| Genscript Biotech Corporation | -95.47 Million USD | 99.937% |
| Ember Therapeutics, Inc. | -23.24 Thousand USD | -160.049% |
| Anthera Pharmaceuticals, Inc. | - USD | Infinity% |
| Sigyn Therapeutics, Inc. | -4.14 Million USD | 98.542% |
| Cotinga Pharmaceuticals Inc. | -2 Million USD | 96.986% |
| Kadimastem Ltd | -3.3 Million USD | 98.173% |
| Helix BioMedix, Inc. | -1.05 Million USD | 94.277% |
| VitaSpring Biomedical Co. Ltd. | - USD | Infinity% |
| Capstone Therapeutics Corp. | -3.81 Million USD | 98.417% |
| BioStem Technologies, Inc. | -8.48 Million USD | 99.288% |
| Oncology Pharma Inc. | - USD | Infinity% |
| Reve Technologies, Inc. | -441.36 Thousand USD | 86.306% |
| LadRx Corporation | 400.44 Thousand USD | 115.093% |
| Cell Source, Inc. | -5.32 Million USD | 98.864% |
| Regen BioPharma, Inc. | 1.02 Million USD | 105.905% |
| Regen BioPharma, Inc. | 1.02 Million USD | 105.905% |
| NovAccess Global Inc. | -4.76 Million USD | 98.733% |
| Affymax, Inc. | -14.42 Million USD | 99.581% |
| Itoco Inc. | -1.86 Million USD | 96.766% |
| Rasna Therapeutics, Inc. | -4.44 Million USD | 98.64% |
| Pathfinder Cell Therapy, Inc. | -1.66 Million USD | 96.379% |
| Mobile Lads Corp. | -2.26 Million USD | 97.33% |
| CytoDyn Inc. | -49.84 Million USD | 99.879% |
| Claritas Pharmaceuticals, Inc. | - USD | Infinity% |
| NDT Pharmaceuticals Inc. | -79.03 Thousand USD | 23.525% |
| NanoSphere Health Sciences Inc. | -228.12 Thousand USD | 73.506% |
| Alseres Pharmaceuticals, Inc. | -941.52 Thousand USD | 93.581% |
| SYBLEU INC | -180.3 Thousand USD | 66.478% |
| Advanced Proteome Therapeutics Corporation | - USD | Infinity% |
| ImmunoCellular Therapeutics, Ltd. | -1.61 Million USD | 96.252% |
| International Stem Cell Corporation | -131 Thousand USD | 53.862% |
| Bioxytran, Inc. | -4.28 Million USD | 98.588% |
| GlobeImmune, Inc. | - USD | Infinity% |
| Predictive Technology Group, Inc. | - USD | Infinity% |
| ProText Mobility, Inc. | -54.27 Thousand USD | -11.366% |
| Cardax, Inc. | - USD | Infinity% |
| VG Life Sciences Inc. | -2.53 Million USD | 97.611% |
| Kaleido Biosciences, Inc. | - USD | Infinity% |
| Advaxis, Inc. | -48.07 Million USD | 99.874% |
| Adhera Therapeutics, Inc. | -2.11 Million USD | 97.141% |
| RenovaCare, Inc. | - USD | Infinity% |
| Regnum Corp. | -780.88 Thousand USD | 92.26% |
| Innovation Pharmaceuticals Inc. | -3.16 Million USD | 98.092% |
| Neutra Corp. | -233.46 Thousand USD | 74.111% |
| Windtree Therapeutics, Inc. | -20.29 Million USD | 99.702% |
| PureTech Health plc | -65.69 Million USD | 99.908% |
| Coeptis Therapeutics, Inc. | -21.26 Million USD | 99.716% |
| IXICO plc | -1.17 Million USD | 94.869% |
| IntelGenx Technologies Corp. | -9.92 Million USD | 99.391% |
| Gelesis Holdings, Inc. | -57.12 Million USD | 99.894% |
| CSL Limited | 2.64 Billion USD | 100.002% |
| Cellectis S.A. | -103.17 Million USD | 99.941% |